Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fatty Liver × Exenatide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 6 Obesity 5 Sexual Infantilism 4 Craniopharyngioma 3 Pancreatic Neoplasms 2 Overweight 2 Weight Loss 1 Insulin Resistance 1 Fatty Liver 1 Diabetes Mellitus, Type 2 1 Diabetes Mellitus, Type 1 1

Interventions

penclomedine 1 atezolizumab 1 Triptorelin Pamoate 1 Tomography, X-Ray Computed 1 Proton Magnetic Resonance Spectroscopy 1 Orchiectomy 1 Olive Oil 1 Metformin 1 Liquid Biopsy 1 Glucose Tolerance Test 1 Exenatide 1 Excitatory Amino Acids 1 Endosonography 1 Diet, Ketogenic 1 Blood Specimen Collection 1 Bevacizumab 1 Amino Acids, Essential 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02157974 2024-06-04

APPLE

University of Colorado, Denver

Phase 2/3 Completed

92 enrolled 17 charts

Fatty Liver, Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡